Annual Total Debt
$46.04 M
-$962.00 K-2.05%
31 December 2023
Summary:
Monte Rosa Therapeutics annual total debt is currently $46.04 million, with the most recent change of -$962.00 thousand (-2.05%) on 31 December 2023. During the last 3 years, it has risen by +$46.04 million (+100.00%). GLUE annual total debt is now -2.05% below its all-time high of $47.00 million, reached on 31 December 2022.GLUE Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Debt
$43.70 M
-$658.00 K-1.48%
30 September 2024
Summary:
Monte Rosa Therapeutics quarterly total debt is currently $43.70 million, with the most recent change of -$658.00 thousand (-1.48%) on 30 September 2024. Over the past year, it has dropped by -$2.70 million (-5.82%). GLUE quarterly total debt is now -10.38% below its all-time high of $48.76 million, reached on 30 June 2022.GLUE Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GLUE Total Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -2.0% | -5.8% |
| 3 y3 years | +100.0% | +100.0% |
| 5 y5 years | - | - |
GLUE Total Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -2.0% | -10.4% | ||
| 5 y | 5 years | -2.0% | -10.4% | ||
| alltime | all time | -2.0% | -10.4% |
Monte Rosa Therapeutics Total Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $43.70 M(-1.5%) |
| June 2024 | - | $44.36 M(-1.8%) |
| Mar 2024 | - | $45.18 M(-1.9%) |
| Dec 2023 | $46.04 M(-2.0%) | $46.04 M(-0.8%) |
| Sept 2023 | - | $46.40 M(-1.4%) |
| June 2023 | - | $47.03 M(+1.9%) |
| Mar 2023 | - | $46.16 M(-1.8%) |
| Dec 2022 | $47.00 M | $47.00 M(+2.9%) |
| Sept 2022 | - | $45.66 M(-6.4%) |
| June 2022 | - | $48.76 M(+598.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $6.98 M(>+9900.0%) |
| Dec 2021 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2021 | - | $0.00(0.0%) |
| June 2021 | - | $0.00(0.0%) |
| Mar 2021 | - | $0.00(0.0%) |
| Dec 2020 | $0.00(-100.0%) | $0.00(0.0%) |
| Sept 2020 | - | $0.00(0.0%) |
| June 2020 | - | $0.00(0.0%) |
| Mar 2020 | - | $0.00 |
| Dec 2019 | $750.00 K | - |
FAQ
- What is Monte Rosa Therapeutics annual total debt?
- What is the all time high annual total debt for Monte Rosa Therapeutics?
- What is Monte Rosa Therapeutics annual total debt year-on-year change?
- What is Monte Rosa Therapeutics quarterly total debt?
- What is the all time high quarterly total debt for Monte Rosa Therapeutics?
- What is Monte Rosa Therapeutics quarterly total debt year-on-year change?
What is Monte Rosa Therapeutics annual total debt?
The current annual total debt of GLUE is $46.04 M
What is the all time high annual total debt for Monte Rosa Therapeutics?
Monte Rosa Therapeutics all-time high annual total debt is $47.00 M
What is Monte Rosa Therapeutics annual total debt year-on-year change?
Over the past year, GLUE annual total debt has changed by -$962.00 K (-2.05%)
What is Monte Rosa Therapeutics quarterly total debt?
The current quarterly total debt of GLUE is $43.70 M
What is the all time high quarterly total debt for Monte Rosa Therapeutics?
Monte Rosa Therapeutics all-time high quarterly total debt is $48.76 M
What is Monte Rosa Therapeutics quarterly total debt year-on-year change?
Over the past year, GLUE quarterly total debt has changed by -$2.70 M (-5.82%)